News Content
Short-term acute reactions are the most common. Approximately 25%-30% of users experience facial flushing and dizziness within 1-2 hours after injection, some accompanied by nausea and palpitations. This is related to the rapid stimulation of the pituitary gland by the drug, triggering a vascular reaction. Injection site reactions occur in about 40% of cases, manifesting as redness, swelling, and stinging. A small number develop local infections due to improper sterilization. The proportion of short-term breast tenderness is significantly higher in female users than in male users, with approximately 18% of women reporting this symptom, which is related to the indirect effects of growth hormone on breast tissue.https://www.fiercerawsource.com/peptides/premium-high-purity-peptides-hexarelin-2mg.html
Long-term use carries more hidden risks. Excessive growth hormone secretion can easily lead to acromegaly, such as thickening of the joints in the hands and feet, and a protruding jaw. The risk increases threefold for those who use it continuously for more than six months. It may also suppress thyroid axis function, with approximately 12% of users experiencing mild hypothyroidism. In individuals with liver or kidney dysfunction, drug metabolism is impaired, potentially leading to abnormal transaminase or creatinine levels.
Experts emphasize: "Hexarelin is a prescription-grade secretagogue; side effects are directly related to dosage and duration. It is by no means a fitness 'performance enhancer' and must be used under medical monitoring. Blindly abusing it carries extremely high risks."
